Growth and hormone profiling in children with congenital melanocytic naevi

被引:18
|
作者
Waelchli, R. [1 ]
Williams, J. [4 ]
Cole, T. [5 ]
Dattani, M. [2 ,6 ]
Hindmarsh, P. [2 ,6 ]
Kennedy, H. [1 ]
Martinez, A. [1 ]
Khan, S. [7 ]
Semple, R. K. [8 ]
White, A. [7 ]
Sebire, N. [3 ]
Healy, E. [9 ]
Moore, G. [6 ]
Kinsler, V. A. [1 ,6 ]
机构
[1] Great Ormond St Hosp Sick Children, Dept Paediat Dermatol, London WC1N 3JH, England
[2] Great Ormond St Hosp Sick Children, Dept Paediat Endocrinol, London WC1N 3JH, England
[3] Great Ormond St Hosp Sick Children, Dept Paediat Histopathol, London WC1N 3JH, England
[4] UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England
[5] UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England
[6] UCL Inst Child Hlth, Dept Genet & Genom Med, London, England
[7] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England
[8] Univ Cambridge, Wellcome Trust MRC Inst Metab Sci, Cambridge, England
[9] Univ Southampton, Sir Henry Wellcome Labs, Dept Dermatopharmacol, Southampton, Hants, England
基金
英国惠康基金;
关键词
BODY-MASS INDEX; NOONAN-SYNDROME; NEUROCUTANEOUS MELANOSIS; THELARCHE VARIANT; COSTELLO SYNDROME; LMS METHOD; CURVES; MALES; UK;
D O I
10.1111/bjd.14091
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Multiple congenital melanocytic naevi (CMN) is a rare mosaic RASopathy, caused by postzygotic activating mutations in NRAS. Growth and hormonal disturbances are described in germline RASopathies, but growth and hormone status have not previously been investigated in individuals with CMN. Objectives To explore premature thelarche, undescended testes, and a clinically abnormal fat distribution with CMN through prospective endocrinological assessment of a cohort of subjects with CMN, and a retrospective review of longitudinal growth of a larger group of patients with CMN from outpatient clinics (which included all subjects in the endocrinological assessment group). Patients and methods Longitudinal growth in a cohort of 202 patients with single or multiple CMN was compared with the U. K. National Child Measurement Programme 2010. Forty-seven children had hormonal profiling including measurement of circulating luteinizing hormone, follicle-stimulating hormone, thyroid stimulating hormone, adrenocorticotrophic hormone, growth hormone, prolactin, pro-opiomelanocortin, estradiol, testosterone, cortisol, thyroxine, insulin-like growth factor-1 and leptin; 10 had oral glucose tolerance testing 25 had dual-energy X-ray absorptiometry scans for body composition. Results Body mass index increased markedly with age (coefficient 0.119, SE 0.016 standard deviation scores per year), at twice the rate of the U. K. population, due to increased adiposity. Three per cent of girls had premature thelarche variant and 6% of boys had persistent undescended testes. Both fat and muscle mass were reduced in areas underlying large naevi, resulting in limb asymmetry and abnormal truncal fat distribution. Anterior pituitary hormone profiling revealed subtle and variable abnormalities. Oral glucose tolerance tests revealed moderate-severe insulin insensitivity in five of 10, and impaired glucose tolerance in one. Conclusions Interpersonal variation may reflect the mosaic nature of this disease and patients should be considered individually. Postnatal weight gain is potentially related to the underlying genetic defect; however, environmental reasons cannot be excluded. Naevus-related reduction of fat and muscle mass suggests local hormonal or metabolic effects on development or growth of adjacent tissues, or mosaic involvement of these tissues at the genetic level. Premature thelarche and undescended testes should be looked for, and investigated, as for any child.
引用
收藏
页码:1471 / 1478
页数:8
相关论文
共 50 条
  • [1] Growth and hormone-profiling in children with congenital melanocytic naevi
    Zeidler, C.
    Luling, H.
    Dieckhofer, A.
    Osada, N.
    Schedel, F.
    Steinke, S.
    Augustin, M.
    Stander, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (01) : 227 - 227
  • [2] Growth and hormonal profiling in children with congenital melanocytic naevi
    Millington, G. W. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (06) : 1366 - 1367
  • [3] Growth and hormone-profiling in children with congenital melanocytic naevi (vol 173, pg 1471, 2015)
    Waelchli, R.
    Williams, J.
    Cole, T.
    Dattani, M.
    Hindmarsh, P.
    Kennedy, H.
    Martinez, A.
    Khan, S.
    Semple, R. K.
    White, A.
    Sebire, N.
    Healy, E.
    Moore, G.
    Kinsler, V. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (01) : 226 - 227
  • [4] Abnormalities of growth and endocrinology in children with congenital melanocytic naevi
    Kinsler, V.
    Hindmarsh, P.
    Dattani, M.
    Cole, T.
    Khan, S.
    White, A.
    Healy, E.
    Sebire, N.
    Moore, G.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 : 131 - 131
  • [5] Congenital melanocytic naevi
    Wlodarkiewicz, Adam
    Sobjanek, Michal
    Michajlowski, Igor
    PRZEGLAD DERMATOLOGICZNY, 2009, 96 (02): : 127 - 132
  • [6] Congenital melanocytic naevi
    Kovalyshyn, Ivanka
    Braun, Ralph
    Marghoob, Ashfaq
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2009, 50 (04) : 231 - 242
  • [7] Lack of effect of growth hormone therapy on the count and density of melanocytic naevi in children
    Zvulunov, A
    Wyatt, DT
    Laud, PW
    Esterly, NB
    BRITISH JOURNAL OF DERMATOLOGY, 1997, 137 (04) : 545 - 548
  • [8] Rapidly Involuting Congenital Melanocytic Naevi in Two Children
    Drakensjo, Iara Trocoli
    Hedblad, Mari-Anne
    Wahlgren, Carl-Fredrik
    ACTA DERMATO-VENEREOLOGICA, 2012, 92 (06) : 605 - 606
  • [9] Melanoma in congenital melanocytic naevi
    Kinsler, V. A.
    O'Hare, P.
    Bulstrode, N.
    Calonje, J. E.
    Chong, W. K.
    Hargrave, D.
    Jacques, T.
    Lomas, D.
    Sebire, N. J.
    Slater, O.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (05) : 1131 - 1143
  • [10] Giant Congenital Melanocytic Naevi
    Mukhopadhyay, Sayeri
    Biswas, Prativa
    Karar, Neha
    Halder, Dipanjan
    Bandyopadhyay, Anjali
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, 18 (02) : SR5 - SR9